This past week, Republicans dialed up the anti-abortion pressure campaign on the Trump Food and Drug Administration when virtually every Republican senator signed a letter to Health Secretary Robert F. Kennedy Jr. asking the FDA to impose new restrictions on mifepristone, a drug currently used in the majority of abortions nationwide.
The senators ask the FDA to suspend further generic approvals, prohibit telehealth access to mifepristone, and immediately stop mifepristone distribution altogether by declaring the drug to be an “imminent hazard” under federal law.
The Trump administration has undertaken a study of mifepristone, which abortion opponents believe will lead to the restoration of pre-2016 restrictions that disallowed telehealth.
We’ve gone from 1 to 2 and they’re itching to finish the job of going from 2 to 3.